Company / FCF Margin
Exelixis FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
37.8%
FY2025
5-year range
16.0% / 53.1%
FY2021-FY2025
Trend
+21.9%
vs FY2024
Sector context
#10 of 133
Health Care
What the data says
Among 133 Health Care companies, Exelixis is in the top 8% for fcf margin. FCF Margin has fluctuated over the past 10 years, ranging from 16.0% in FY2023 to 561.4% in FY2016.
Based on SEC 10-K filings.
37.8% in FY2025 with a 5-year CAGR of +19.7%. Top quartile in the Health Care sector.
Improved from 16.0% to 37.8% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +19.7pp
- 5-Year Change
- +19.7pp
- 10-Year Change
- -
Sector benchmark
Top 8% in Health CareTop 8% of 133This company 37.8% Sector average -632.8%
▼
+106.0% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 21.9% year-over-year.
- Currently 670.6pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2016.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 37.8% | +21.9% |
| FY2024 | 31.0% | +93.5% |
| FY2023 | 16.0% | -11.6% |
| FY2022 | 18.1% | -65.9% |
| FY2021 | 53.1% | +193.6% |
| FY2020 | 18.1% | -65.9% |
| FY2019 | 53.1% | -51.3% |
| FY2018 | 109.0% | -39.0% |
| FY2017 | 178.6% | -68.2% |
| FY2016 | 561.4% | +246.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026